Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation

Clinical trial NCT05404711 · COMPLETED

Trial details

NCT number

NCT05404711

Sponsor

Mary Ellen Vajravelu, MD

Status

COMPLETED

Phase

Not Applicable

Study type

INTERVENTIONAL

Start date

2022-10-11

Primary completion

2023-11-21

Enrollment

40

View on ClinicalTrials.gov